Grants and Contracts Details
Abstract The Don S. Fredrickson Lipid Research Conference (formerly the Southeast Lipid Research Conference (SELRC)) brings together scientists and trainees investigating the impact of lipid and lipoprotein metabolism on the development and treatment of Cardiometabolic disease. Due changes in Beginning in 2016 the Fredrickson Conference employed an institutional host model. The first which was held at the University of Kentucky in conjunction with the the Saha Cardiovascular Research Center and Gill Heart Center Cardiovascular Research Day. Since 2016, the Fredrickson Conference has been hosted by Vanderbilt University and the University of Cincinnati. Following a return to UK in 2021, the conference will be hosted by Duke University and the University of North Carolina in 2022, Vanderbilt University in 2023, and The Medical College of Wisconsin in 2024. The move to the institutional-host model resulted in a substantial increase in attendance and a larger geographical footprint that extended beyond the Southeast. With the blessing of the family, the board voted to rename the SELRC after the late Don S. Fredrickson. Dr. Fredrickson served as the director of the National Heart Institute (now the NHLBI) from 1966 – 1974 and later the NIH, developed the clinical classification for dyslipidemias (Type I-V), described Tangier’s Disease, and made seminal discoveries in the area of lipoprotein metabolism. Most importantly, he trained both basic and clinical scientists and practitioners who have had a tremendous impact on the field of lipoprotein metabolism. Keynote Lectures at the 2022 Fredrickson conference include Karen Mohlke, University of North Carolina and Debbie Muoio, Duke University on Days 1 and 3 of the conference. The scientific sessions include Novel Models in Lipid Metabolism, Adipose Tissue, Lipoprotein Metabolism, and Lipids and Body Composition. Day 2 of the conference will be sponsored by the North Carolina Diabetes Research Center The agenda includes additional scientific sessions; multiple “Poster Pitch” sessions (5-7, 90-second presentations by trainees) and two judged poster sessions. The combined agenda affords every trainee in attendance the opportunity to present their research on stage, network with leaders in the field, and broaden their scope and understanding of research in lipid metabolism and Cardiometabolic Diseases.
|Effective start/end date||8/1/22 → 7/31/23|
- National Heart Lung and Blood Institute: $17,000.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.